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Abstract
Background: The diagnosis of Coeliac disease (CD) requires a combination of sign/symptoms, positivity of specific
antibodies and duodenal histological evidence of villous atrophy. Duodenal villous atrophy, despite representing
the CD landmark, is not specific since it is found in many gastrointestinal disorders. Giardiasis is one of the most
common human intestinal protozoan infestations in industrialized countries whose histological duodenal mucosa
damage could mimic that of CD. The present report shows how a wise clinical and laboratory assessment led us
shortly to a correct diagnosis.
Case presentation: A 42-year-old outpatient woman without previous significant gastrointestinal diseases, was
referred with dyspeptic symptoms, fatigue and mild diarrhea from 4 months. Her first investigations including
immunoglobulin A (IgA) anti-tissue transglutaminase antibodies (anti-tTG) and stool parasitological and cultural
analysis were negative. An esophagogastroduodenoscopy (EGDS) showed no mucosal alteration. But histology
demonstrated a Helicobacter Pylori (HP) pan-gastritis while duodenal mucosa showed villous atrophy consistent
with a diagnosis of CD Marsh type 3b. While on gluten-free diet (GFD) the patient didn’t experience any
improvement of symptoms. Duodenal biopsies were then reviewed showing the presence of trophozoites of
Giardia on the luminal surface of the duodenal wall and at the same time, a second stool examination revealed
the presence of trophozoites and cysts of Giardia. Treated with metronidazole, 500 mg twice daily for 6 days the
patient reduced diarrhea after few days. After about 2 months of GFD she was invited to discontinue it. At the
same time stool examination was repeated with negative results. She subsequently performed eradication for Hp
with triple therapy (Pylera®). Around 6 months later, the patient did not complain any gastrointestinal symptoms.
Serological tests were normal and at a follow-up EGDS, duodenal mucosa had normal histology with normal
finger-like villi and absence of Giardia trophozoites.
Conclusion: This case report shows how CD diagnosis can sometimes be manifold. Intestinal villous atrophy alone
may not automatically establish a diagnosis of CD. In the present case the clinical scenario could be fully explained
by giardiasis. Indeed, different diagnostic tools and a multi-step approaches have been used to determine the final
correct diagnosis.
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Background
Coeliac disease (CD) is an immune-mediated enterop-
athy caused by an immune response to dietary gluten
in genetically predisposed individuals. In Europe the es-
timated median prevalence in the general population is
about 1% [1].
The definite diagnosis of CD requires a combination
of sign/symptoms, positivity of specific antibodies
(anti-transglutaminase and anti-endomysium) and duo-
denal histological evidence of villous atrophy associated to
crypt hyperplasia and intraepithelial lymphocytosis [2].
Due to its heterogeneous manifestations, the relatively
high percentage of false negative results of specific anti-
bodies [3] and histological evaluation, CD diagnosis is
sometimes challenging. In addition, the presence of duo-
denal villous atrophy, despite representing the CD land-
mark, is not specific since it could be a sign of other
gastrointestinal disorders [4].
For these reasons, further investigations such as
genetic evaluation (HLA) and/or gluten challenge with
subsequent follow-up esophagogastroduodenoscopy with
duodenal biopsies including the research of parasitic
infections can be useful in selected cases.
Concerning our case, it is known that giardiasis is one
of the most common human protozoan infestations in in-
dustrialized countries [5] with selective intestinal tropism,
particularly for the duodenum, where the histological
damage could mimic that of CD.
We aim to illustrate how a strict clinical observation
led us to clarify in a short time a misdiagnosis of CD.
Case presentation
A 42-year-old woman, married and with two children, was
referred to our hospital outpatient gastrointestinal clinic
for a 4 months’ history of post-prandial heartburn with
frequent regurgitations, fatigue and change in bowel
movements (4–5 soft stools). At the moment of the first
consult, a written informed consent on the publication of
personal information was obtained from the patient. She
had experienced unintentional weight loss of 3 kg in about
one month despite normal or even increased food intake.
In her clinical history no previous significant gastrointes-
tinal symptoms were present. The patient’s older sister
had been diagnosed of coeliac disease at age 20. Her
personal and family history was otherwise unremarkable.
She first underwent biochemical investigations including
immunoglobulin A (IgA) anti-tissue transglutaminase
antibodies (anti-tTG) and stool parasitological and cul-
tural analysis. Serological testing showed normal IgA
levels and negativity for anti-tTG levels and antiendomy-
sial antibodies (Ema). The patient’s ferritin was 33 mg/l
(n.v. 30–400 mg/l), serum folate was lower than 5 nmol/l
(n.v. > 7 nmol/l), haemoglobin level was normal as well as
white blood cells and platelet count. The result of stool
analysis was negative for parasites and ova. Since symp-
toms persisted, she was then referred for an upper GI
endoscopy. Esophageal and gastric mucosa did not show
any macroscopic alterations. Duodenal folds were normally
represented as well as mucosa. Multiple gastric antrum and
corpus-fundus mucosa biopsies were taken along with
biopsies from the bulb and second part of duodenum (at
least four).
Gastric biopsies showed a Helicobacter Pylori (HP)
pan-gastritis while duodenal mucosa showed villous atro-
phy (Fig. 1) associated with an increase in intraepithelial T
lymphocyte (IEL) numbers up to more than 40 IEL/100
epithelial cells (EC), recognized by CD3 immunostaining
(Fig. 2). The histologic features were consistent with a
diagnosis of coeliac disease Marsh type 3b [6, 7]. She was
informed of the result and advised to begin gluten-free
diet (GFD). After 4 weeks of GFD the patient didn’t
experience any improvement of symptoms, and bowel
movements with abdominal pain increased to around 6–7
daily; she was advised to prompting repeat further stool
examinations. Genetic evaluation for alleles HLA specific
for coeliac disease was also requested. At the same time,
in order to re-evaluate initial diagnosis, duodenal biopsies
were reviewed and a careful study of the duodenal mucosa
showed the presence of scattered crescent-shaped ran-
domly oriented trophozoites of Giardia on the luminal
surface of the duodenal wall (Fig. 3). The organisms were
minute, easily overlooked or mistaken for detached intes-
tinal epithelial cells or erythrocytes. Subsequently, results
of the second stool examinations revealed the presence of
G. lamblia with findings of trophozoites and cysts. The
patient was consequently treated with metronidazole,
500 mg twice daily for 6 days, showing a prompt response
with a reduced frequency of diarrhea in the following days.
The genetic results showed DQA1*03 and DQB1*03:02
alleles codifying for HLA-DQ8, otherwise compatible with
CD diagnosis. In the following weeks, the patient intermit-
tently maintained a GFD, but observed no difference in
her well-being. Stool examination was repeated 2 months
after the end of antibiotic therapy with negative results.
After about 2 months of GFD she was invited to discon-
tinue it. She subsequently performed eradication therapy
for HP with triple therapy of metronidazole, tetracycline
and bismuth (Pylera®).
Around 6 months later, the patient did not complain
gastrointestinal symptoms. In January 2017 she repeated
serological tests and a follow-up esophagogastroduodeno-
scopy. No alterations were found in haemoglobin, folic
acid, cholesterol, triglycerides and antibodies (anti-tTG
and Ema) levels. Multiple duodenal biopsies were per-
formed, showing normal histologic appearance of the mu-
cosa with normal finger-like villi, no evidence of increased
IEL numbers and complete absence of crescent-shaped
Giardia trophozoites (Fig. 4). The gastric biopsies showed
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resolution of active HP gastritis. The patient showed no
clinical signs of CD and the conclusion was that the clin-
ical scenario could be fully explained by giardiasis.
Discussion and conclusions
This case report demonstrates how differential diagnosis
can be challenging in coeliac disease diagnostic work-up.
Differently from the past, presence of duodenal villous
atrophy cannot be defined as coeliac disease landmark
at first sight [4]. Nowadays, the morphologic/histological
changes in coeliac disease are characteristic but not specific
and they must be evaluated in conjunction with clinical and
laboratory evidence such as malabsorption, specific
serum antibody levels and response to a gluten-free diet
Fig. 2 CD3 immunostaining of duodenal mucosa showing an increased number of CD3+ T IEL (× 320)
Fig. 1 Duodenal mucosa showing villous atrophy associated with increased intraepithelial lymphocyte (IEL) numbers and an unusual large number of
intraepithelial granulocytes. The lamina propria is completely filled by chronic inflammatory cells with some scattered eosinophils (H&E, × 400)
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[8]. Various other pathological conditions mimicking
coeliac disease may cause malabsorption syndrome [9]. In
Giardiasis, the villous architecture is usually normal (96%
of investigated patients) [5], mainly affecting the lamina
propria, in which lymphoid hyperplasia and increased
numbers of chronic inflammatory cells and eosinophils
are seen. Sometimes, Giardia lamblia can induce increase
of duodenal intraepithelial lymphocytes associated or not
to crypt hyperplasia and different grades of villous atrophy
[10–12]. These alterations lead to a significant range of
symptoms going from abdominal chronic pain to diarrhea
and signs of malabsorption [13].
Fig. 3 Duodenal mucosa showing the presence of scattered crescent-shaped randomly oriented trophozoites of Giardia on the luminal surface of
the duodenal wall (H&E, × 400)
Fig. 4 Duodenal mucosa showing a normal histologic appearance with normal finger-like villi, no evidence of increased IEL numbers and complete
absence of crescent-shaped Giardia trophozoites (H&E, × 400)
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In this case, the mucosa was mainly affected by evident
villous atrophy associated with massive intraepithelial
lymphocytosis and rich infiltration in the lamina propria
by inflammatory cells. On this basis, the histologic fea-
tures were more consistent with a diagnosis of coeliac dis-
ease rather than of duodenal Giardia infection.
However, only accurate clinical information associated
with a thorough evaluation of duodenal mucosa was able
to avoid misdiagnosis of coeliac disease in the present
case of Giardia lamblia infection.
Discerning coeliac disease from Giardiasis is pivotal in
order to proceed to adequate treatment. In this specific
case report, strict follow-up played a key-role in achiev-
ing the final diagnosis in a limited time. In the present
case, re-evaluation of clinical history and the further
investigations carried out allowed to reach a final correct
diagnosis in a relatively short period of time.
Recent case series and systematic reviews have shown
that a wrong CD diagnosis can be reached in a consistent
percentage of seronegative patients [3, 12]. In fact, a re-
cent study on 200 seronegative patients showed a percent-
age of seronegative non-coeliac disease patients of 69%
[14]. These patients had different causes of villous
atrophy, such as giardiasis, drugs mucosal damage, Crohn
disease and autoimmune enteropathy; even if some cases
remained unknown [12, 14]. Until 10 years ago, preva-
lence of seronegative CD was reported to be around 10 to
20% [15, 16]. Nowadays, due to the increased sensitivity of
serological assays (anti-tTG and Ema detection) and to
the acknowledgement of different alternative diagnosis of
villous atrophy and their specific diagnostic work-up, this
percentage decreased to 3–5% of the total number of pa-
tients with a real diagnosis of CD [12, 17].
For these reasons, clinical, biochemical and histo-
logical re-evaluation is mandatory in some settings. Also
γδ intraepithelial lymphocytes evaluation through flow
cytometry could be a useful tool to exclude differential
diagnosis [18].
It has been reported that about 0.11% of patients of
industrialized countries presented with overt Giardia
duodenalis infection [5]. However, the same countries
have shown a giardia seroprevalence up to 2%. The gold
standard for Giardia infection diagnosis is the micro-
scopic analysis of fecal samples in order to search for
cysts and trophozoites [19], but false-negative results
are commonly found due to variable parasite excretion,
cyclicity of cysts or due to a low number of organisms
present in the sample [20]. Considering also our case
report, in case of high suspicious of parasitic infection,
we suggest the examination of 3 stool samples or other
diagnostic tests such as ELISA (enzyme-linked immuno-
sorbent assay), rapid tests (immunochromatographic
tests), and the detection of Giardia specific genes by PCR
in order to avoid false negative results.
In conclusion, our case report underlines how villous at-
rophy alone may not automatically establish a diagnosis of
celiac disease. Indeed, since intestinal villous atrophy can
be associated to other intestinal and/or systemic diseases,
when considering coeliac disease and its differential diag-
nosis, a pivotal importance must be recognized to clinical
scenario and antibodies positivity. This case report clearly
shows how CD diagnosis can sometimes be manifold.
Indeed, different diagnostic tools and a multi-step ap-
proaches have been used to determine the final diagnosis.
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